Throughout the course of living with Parkinson's disease, you may receive different drugs at different times. We would like to help you learn more regarding your treatment options by e-mailing you information about AZILECT®, the first once-daily treatment for people with PD.

Please take a moment to answer these few survey questions.

*Your email address:
*Confirm email:
*First name:
*Last name:

*Indicates required fields

The information supplied here will be held in the strictest confidence, and not shared with anyone outside Teva Neuroscience, Inc. or its authorized representatives.

Your privacy is important to us, and the information you provide will be held in the strictest confidence and not shared with anyone outside Teva Neuroscience, Inc. or its authorized representatives.

Please read the following paragraph carefully and click the appropriate box below:

I understand and agree that the information I provide here may be used by Teva Neuroscience and its business partners to provide me information about Teva Neuroscience’s products and educational materials that may be of interest to me, and to develop future products, services and programs for people living with PD.

*
 
 


d ©2007 Teva Neuroscience, Inc.      Important Safety Information      Prescribing Information